Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03430362 |
Other study ID # |
25 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 2, 2018 |
Est. completion date |
February 16, 2020 |
Study information
Verified date |
September 2021 |
Source |
Cairo University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Women will be admitted when active phase of labour starts defined as the presence of at least
three regular uterine contractions over 10 minutes with cervical dilatation four centimeters
with cervical effacement not less than 50% and no progress of labor for 2 hours or more.
Amniotomy was done in those with intact membrane and continuous electronic fetal monitoring
was done. Women with prolonged labor after these measures were randomly divided using
automated web-based randomization system into 2 equal groups. Group I included 50 women
received 40mg HBB (Buscopan, Memphis Co, Giza, Egypt) intravenous bolus injection. Group II
included 50 women received 2 ml of normal saline. The obstetrician, participants and outcome
assessor were all blinded to the group assignment. Labor will be monitored by Vaginal
examination every two hours. The duration of the first stage was calculated from the time of
cervical dilatation of three to four centimeters in active labor until a fully dilated cervix
was observed.
Description:
Women will be admitted when active phase of labour starts defined as the presence of at least
three regular uterine contractions over 10 minutes with cervical dilatation four centimeters
with cervical effacement not less than 50% and no progress of labor for 2 hours or more.
Amniotomy was done in those with intact membrane and continuous electronic fetal monitoring
was done. Women with prolonged labor after these measures were randomly divided using
automated web-based randomization system into 2 equal groups. Group I included 50 women
received 40mg HBB (Buscopan, Memphis Co, Giza, Egypt) intravenous bolus injection. Group II
included 50 women received 2 ml of normal saline. The obstetrician, participants and outcome
assessor were all blinded to the group assignment. Labor will be monitored by Vaginal
examination every two hours. The duration of the first stage was calculated from the time of
cervical dilatation of three to four centimeters in active labor until a fully dilated cervix
was observed.